Published in Medical Verdicts and Law Weekly, March 18th, 2004
Under CMS guidelines the company submitted a Formal Request for Reconsideration outlining an error in a decision that had become effective April 1, 2003, that omitted Diapulse from Medicare coverage for treatment of chronic wounds.
Over a 17-month period, David M. Ross, VP of Diapulse Corporation of America, met with CMS and supplied information that was instrumental in convincing CMS to reverse a previous national...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.